Advertisement

Topics

China Biologic Products, Inc. Company Profile

17:59 EDT 23rd September 2017 | BioPortfolio

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state- owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.


News Articles [3293 Associated News Articles listed on BioPortfolio]

China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London

BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the ...

China Biologic Products to Report Second Quarter of 2017 Financial Results

BEIJING, July 19, 2017 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China...

China Biologic Products to Report Second Quarter 2012 Financial Results

BEIJING, August 3, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutica...

China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)

BEIJING, May 7, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the ...

Hangzhou Just Bio Raises $57 Million for Biologic Drug Development

Hangzhou Just Biotherapeutics (Just China), a company focused on providing affordable biologic drugs, completed a $57 million Series B funding. Just China is developing a portfolio of innovative and b...

Harbour BioMed to develop and commercialise HanAll’s biologic therapies in Greater China

South Korean pharmaceutical company HanAll Biopharma has entered a strategic collaboration and licence agreement with China-based Harbour BioMed for the development, production and commercialisation o...

China Biologic Products' (CBPO) CEO David Gao on Q2 2017 Results - Earnings Call Transcript

China Biologic Products Reports Financial Results For The Second Quarter Of 2017

  Life Sciences Jobs   ...

Drugs and Medications [476 Associated Drugs and Medications listed on BioPortfolio]

Antibacterial hand [Crown Products, LLC]

Antibacterial Hand Spray

Instant hand sanitizer citrus scent [Crown Products, LLC]

Instant Hand Sanitizer Citrus Scent

Antibacterial hand sanitizer citrus scent [Crown Products, LLC]

Antibacterial Hand Sanitizer Spray Citrus Scent

Antibacterial hand sanitizer citrus scent [Crown Products, LLC]

Antibacterial Hand Sanitizer Spray Citrus Scent

Isopropyl alcohol antiseptic germicide [PSS World Medical]

Isopropyl Alcohol Swabsticks (3's) Antiseptic Germicide

PubMed Articles [2451 Associated PubMed Articles listed on BioPortfolio]

Design control considerations for biologic-device combination products.

Combination products are therapeutic and diagnostic medical products that combine drugs, devices, and/or biological products with one another. Historically, biologics development involved identifying ...

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.

This study assessed the occurrence of indicators for suboptimal biologic therapy among ulcerative colitis (UC) and Crohn's disease (CD) patients over time in the United States (US). Data from a large ...

Patterns of Care for Biologic-Dosing Outliers and Nonoutliers in Biologic-Naive Patients with Rheumatoid Arthritis.

Although most biologic medications for patients with rheumatoid arthritis (RA) have recommended fixed dosing, actual biologic dosing may vary among real-world patients, since some patients can receive...

Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

Systemic biologic and nonbiologic agents used to treat psoriasis may or may not contribute to serious infection (SI) risk. Safety data, particularly for biologic agents, and associated risk for SI, ar...

Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study.

Although biologics are important inflammatory bowel disease therapies, loss of response (LOR) remains problematic. We evaluated LOR to biologics in our Crohn disease (CD) patients receiving biologics....

Clinical Trials [1790 Associated Clinical Trials listed on BioPortfolio]

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction

To date, there have been no prospective randomized controlled trials that compare various biologic mesh materials in the context of abdominal wall reconstruction. As a result, this proposa...

Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair

The purpose of this trial is to collect safety and effectiveness data to support peripheral vascular indication of XenoSure biologic patch. This trial is performed to meet the China FDA re...

Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair

The purpose of this clinical trial is to collect safety and effectiveness data to support cardiac repair indication of XenoSure biologic patch. This trial is performed to meet the China FD...

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

This study is designed to analyze the frequency and incidence rate of pulmonary complications in JIA participants who received biological DMARDs and non-biologic DMARDs. The participants h...

Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study

An important reason for the costs of hemodialysis treatment in China are expensive is the hemodialysis machine and related products mainly rely on imports. Hemodialysis machine is the basi...

Companies [982 Associated Companies listed on BioPortfolio]

China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and...

China Agritech, Inc.

China Agritech, Inc. is engaged in the development, manufacture and distribution of liquid and granular organic compound fertilizers and related products in China. The Company has developed propri...

China Kangtai Cactus Bio-tech Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy...

China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy ...

China Kangtai Cactus Bio-tech, Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy...

More Information about "China Biologic Products, Inc." on BioPortfolio

We have published hundreds of China Biologic Products, Inc. news stories on BioPortfolio along with dozens of China Biologic Products, Inc. Clinical Trials and PubMed Articles about China Biologic Products, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Biologic Products, Inc. Companies in our database. You can also find out about relevant China Biologic Products, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record